Breast cancer trial asks: can we ditch the painful shot?
NCT ID NCT05753618
Summary
This study is testing if breast cancer patients can safely skip a standard injection (G-CSF) during part of their chemotherapy. The injection helps prevent infection but often causes severe bone pain. Researchers want to see if skipping it reduces pain and improves quality of life without increasing other risks for 242 patients with early-stage breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kingston Health Sciences Centre
RECRUITINGKingston, Ontario, K7L 2V7, Canada
-
Lakeridge Health
RECRUITINGOshawa, Ontario, L1G 2B9, Canada
-
The Ottawa Hospital Cancer Centre
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.